In this article from Argentina, the researchers looked at the changes
in disease activity in patients with relapsing-remitting MS having
assisted reproduction technology (ART) infertility treatment. Sixteen
patients were followed for 12 months prior to the first cycle of
treatment and then 9 months after the last cycle. During this time,
tests carried out included neurological examination, brain MRI and
immunology testing every 3 months.
Overall, the study showed
that there was a significant rise in MS disease activity in patients
receiving ART infertility treatment.
authors: Correale J, Farez MF, Ysrraelit MC.
source: Ann Neurol. 2012 Oct 3. [Epub ahead of print]
Read the abstract